389 related articles for article (PubMed ID: 8370085)
1. Gastroretentive dosage forms.
Moës AJ
Crit Rev Ther Drug Carrier Syst; 1993; 10(2):143-95. PubMed ID: 8370085
[TBL] [Abstract][Full Text] [Related]
2. Gastroretentive dosage forms: overview and special case of Helicobacter pylori.
Bardonnet PL; Faivre V; Pugh WJ; Piffaretti JC; Falson F
J Control Release; 2006 Mar; 111(1-2):1-18. PubMed ID: 16403588
[TBL] [Abstract][Full Text] [Related]
3. [Comparative evaluation of the gastric transit of floating and non-floating matrix dosage forms].
Timmermans J
Bull Mem Acad R Med Belg; 1990; 145(8-9):365-75. PubMed ID: 2099235
[TBL] [Abstract][Full Text] [Related]
4. Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: new data for reconsidering the controversy.
Timmermans J; Moës AJ
J Pharm Sci; 1994 Jan; 83(1):18-24. PubMed ID: 8138903
[TBL] [Abstract][Full Text] [Related]
5. Gastroretentive dosage forms: a review with special emphasis on floating drug delivery systems.
Pawar VK; Kansal S; Garg G; Awasthi R; Singodia D; Kulkarni GT
Drug Deliv; 2011 Feb; 18(2):97-110. PubMed ID: 20958237
[TBL] [Abstract][Full Text] [Related]
6. Alginate microspheres of isoniazid for oral sustained drug delivery.
Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
[TBL] [Abstract][Full Text] [Related]
7. [Gastroretentive dosage forms].
Kiss D; Zelkó R
Acta Pharm Hung; 2005; 75(3):169-76. PubMed ID: 16318241
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical approaches to colon targeted drug delivery systems.
Chourasia MK; Jain SK
J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans.
Sato Y; Kawashima Y; Takeuchi H; Yamamoto H
Int J Pharm; 2004 May; 275(1-2):97-107. PubMed ID: 15081141
[TBL] [Abstract][Full Text] [Related]
10. Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: preparation and in vitro characterization.
Jain SK; Awasthi AM; Jain NK; Agrawal GP
J Control Release; 2005 Oct; 107(2):300-9. PubMed ID: 16095748
[TBL] [Abstract][Full Text] [Related]
11. Gastric retentive drug-delivery systems.
Hwang SJ; Park H; Park K
Crit Rev Ther Drug Carrier Syst; 1998; 15(3):243-84. PubMed ID: 9699081
[TBL] [Abstract][Full Text] [Related]
12. Development of sustained release gastroretentive drug delivery system for ofloxacin: in vitro and in vivo evaluation.
Chavanpatil M; Jain P; Chaudhari S; Shear R; Vavia P
Int J Pharm; 2005 Nov; 304(1-2):178-84. PubMed ID: 16198522
[TBL] [Abstract][Full Text] [Related]
13. Formulation strategies for absorption windows.
Davis SS
Drug Discov Today; 2005 Feb; 10(4):249-57. PubMed ID: 15708743
[TBL] [Abstract][Full Text] [Related]
14. Compressed collagen sponges as gastroretentive dosage forms: in vitro and in vivo studies.
Gröning R; Cloer C; Georgarakis M; Müller RS
Eur J Pharm Sci; 2007 Jan; 30(1):1-6. PubMed ID: 17101267
[TBL] [Abstract][Full Text] [Related]
15. Oxprenolol-loaded bioadhesive microspheres: preparation and in vitro/in vivo characterization.
Preda M; Leucuta SE
J Microencapsul; 2003; 20(6):777-89. PubMed ID: 14594666
[TBL] [Abstract][Full Text] [Related]
16. Floating microspheres: to prolong the gastric retention time in stomach.
Bhadouriya P; Kumar M; Pathak K
Curr Drug Deliv; 2012 May; 9(3):315-24. PubMed ID: 22023206
[TBL] [Abstract][Full Text] [Related]
17. Drug delivery to the upper small intestine window using gastroretentive technologies.
Streubel A; Siepmann J; Bodmeier R
Curr Opin Pharmacol; 2006 Oct; 6(5):501-8. PubMed ID: 16890020
[TBL] [Abstract][Full Text] [Related]
18. Gastroretentive drug delivery systems.
Streubel A; Siepmann J; Bodmeier R
Expert Opin Drug Deliv; 2006 Mar; 3(2):217-33. PubMed ID: 16506949
[TBL] [Abstract][Full Text] [Related]
19. Transit of pharmaceutical dosage forms through the small intestine.
Davis SS; Hardy JG; Fara JW
Gut; 1986 Aug; 27(8):886-92. PubMed ID: 3732895
[TBL] [Abstract][Full Text] [Related]
20. Specific aspects of gastro-intestinal transit in children for drug delivery design.
Bowles A; Keane J; Ernest T; Clapham D; Tuleu C
Int J Pharm; 2010 Aug; 395(1-2):37-43. PubMed ID: 20478372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
